Skip to main content

Table 1 Comparison of General Data between the two Groups

From: Analysis of risk factors of preeclampsia in pregnant women with chronic hypertension and its impact on pregnancy outcomes

Variable

Non-occurrence Group (n = 200)

Occurrence group (n = 300)

t/χ2/Z value

P value

Age (years-old, x ± s)

33.69 ± 5.80

32.74 ± 5.25

1.557

0.120

Primipara (n, %)

104(52.00)

146(48.70)

0.533

0.465

Pre-delivery BMI [kg/m2, M (Q1, Q3)]

30.00 (27.38, 32.23)

31.51 (29.21, 34.91)

-1.610

0.107

History of preeclampsia (n, %)

8(4.00)

74(24.67)

37.383

< 0.001

Positive antiphospholipid antibody (n, %)

5(2.50)

13(4.33)

1.162

0.281

Gravidity [n, M (Q1, Q3)]

2.00 (1.00, 3.00)

2.00 (1.00, 3.00)

-1.159

0.246

Parity [n, M (Q1, Q3)]

0.00 (0.00, 1.00)

0.00 (0.00, 1.00)

-0.531

0.595

Family history of hypertension (n, %)

3(1.50)

5(1.67)

0.021

0.884

Duration of hypertension > 3 years (n, %)

36(18.00)

95(31.67)

11.592

< 0.001

Systemic treatment (n, %)

41(20.50)

30(10.00)

10.859

< 0.001

Gestational age at admission [Weeks, M (Q1, Q3)]

37.72 (34.10, 38.71)

35.01 (31.91, 37.42)

-9.825

< 0.001